Lipodystrophy, insulin resistance, and adiponectin concentration in HIV-infected children and adolescents

Current HIV Research

Volumn 9, Issue 5, 2011, Pages 321-326

  Viganò, Alessandra ^a   Zuccotti, Gian Vincenzo ^a   Cerini, Chiara ^a   Stucchi, Sara ^a   Puzzovio, Maria ^b   Giacomet, Vania ^a   Mora, Stefano ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Adiponectin; Body composition; Children; Insulin resistance; Lipodystrophy; Oral glucose tolerance test

Indexed keywords

ADIPONECTIN; INSULIN;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; BODY COMPOSITION; CHILD; CHILDHOOD DISEASE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOATROPHY; LIPODYSTROPHY; LIPOHYPERTROPHY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADOLESCENT; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AREA UNDER CURVE; BODY COMPOSITION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOSE TOLERANCE TEST; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; YOUNG ADULT;

EID: 80053970526     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211797635946     Document Type: Article

References (35)

1. The antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293-9.
2. Calmy A, Hirschel B, Cooper DA, et al. A new era of antiretroviral drug toxicity. Antivir Ther 2009; 14: 165-79.
3. Palacios R, Merchante N, Macias J, et al. Incidence of and risk factors for insulin resistance in treatment-naïve HIV-infected patients 48 weeks after starting highly active antiretroviral therapy. Antivir Ther 2006; 11: 529-35.
4. Grunfeld C, Rimland D, Gibert CL, et al. Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr 2007; 46: 283-90.
5. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-8.
6. Joly V, Flandre P, Meiffredy V, et al. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS 2002; 16: 2447-54.
7. Brambilla P, Bricalli D, Sala N, et al. Highly active antiretroviraltreated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS 2001; 15: 2415-22.
8. Bitnun A, Sochett E, Babyn P, et al. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naïve HIV-infected children. AIDS 2003; 17: 1319-27.
9. Viganò A, Mora S, Testolin C, et al. Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. J Acquir Immune Defic Syndr 2003; 32: 482-9.
10. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 2004; 18: 1443-51.
11. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001; 29: 72-5.
12. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329-39.
13. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-9.
14. Matsubara K, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-80.
15. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-9.
16. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
17. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-6.
18. Stefan N, Stumvoll M, Vozarova B, et al. Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 2003; 26: 3315-9.
19. Kern PA, Di Gregorio GB, Lu T, et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003; 52: 1779-85.
20. Abbasi F, Chu JW, Lamendola C, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004; 53: 585-90.
21. Haque WA, Shimomura I, Matsuzawa Y, et al. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002; 87: 2395-8.
22. Mynarcik DC, Combs T, McNurlan MA, et al. Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. J Acquir Immune Defic Syndr 2002; 31: 514-20.
23. Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNF-a, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 2003; 285: E1072-80.
24. Addy CL, Gavrila A, Tsiodras S, et al. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 2003; 88: 627-36.
25. Tong Q, Sankalé JL, Hadigan CM, et al. Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab 2003; 88: 1559-64.
26. Verkauskiene R, Dollfus C, Levine M, et al. Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome. Pediatr Res 2006; 60: 225-30.
27. Kim RJ, Carlow DC, Rutstein JH, et al. Hypoadiponectinemia, dyslipidemia, and impaired growth in children with HIV-associated facial lipoatrophy. J Pediatr Endocrinol Metab 2007; 20: 65-74.
28. Krause JC, Toye MP, Fisher DJ, et al. Metabolic abnormalities in human immunodeficiency virus-infected children: two-year followup. J Pediatr Endocrinol Metab 2009; 22: 345-51.
29. Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI (6 - 20 y). Eur J Clin Nutr 2002; 56: 171-80.
30. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty. Arch Dis Child 1976; 51: 170-9.
31. Njeh CF, Samat SB, Nightingale A, et al. Radiation dose and in vitro precision in paediatric bone mineral density measurement using dual X-ray absorptiometry. Br J Radiol 1997; 70: 719-27.
32. Matthews DR, Hosker JP, Rudesnski AS, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
33. HIV Lipodystrophy Case Definition Study Group. An objective case definition of lipodystrophy in HIV-infected adults: a casecontrol study. Lancet 2003; 361: 726-35.
34. Alberti KGMM, Zimmer PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1.: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998; 15: 539-53.
35. Alberti KGMM, Zimmet PZ, Shaw J, et al. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-62.